In California, biomanufacturing firm ZymoChem has closed a $21 million Series A to advance its first product to commercial scale. The round was led by Breakout Ventures and included new investors lululemon, a producer of high-end athletic apparel, and Toyota Ventures. Returning investors GS Futures, KdT Ventures, and Cavallo Ventures also participated.
ZymoChem’s technology uses proprietary, carbon-conserving microbes to convert renewable feedstocks into biobased materials without compromising price, performance, scale, or sustainability.
“ZymoChem has the most compelling technology we’ve seen to scale bio-based chemicals and materials while remaining cost competitive with petroleum-derived products,” Lindy Fishburne, Managing Partner at Breakout, said in a press statement.